Table 1.

The number of SFC in human PBMCs incubated with HBV surface antigen likewise resulted in an 85%–100% increase in IFNγ SFC before (A) and after (B) treatment with IMM124E

A: Average # of spots before IMM124E
	Negative	Covid‐19	Hepatitis
Patient 1	0	1.0	0.3
Patient 2	0.5	1.3	0.3
Patient 3	0.5	4.3	2.3
Patient 5	0.5	2.7	2.0

B: Average # of spots after IMM124E
	Negative	Covid‐19	Hepatitis
Patient 1	9	14.3	13.7
Patient 2	3.5	7.3	5.0
Patient 3	22	34.7	65.3
Patient 5	30	54.3	41.7